Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

New short interest information will be out tonight, maybe tomorrow. It seems as if with Platinum selling unlimited quantities of shares, Crede seemingly shorting as well (against their warrants), our old shorts currently with approximately 20,000,000 shares bet against the company, and the dilution overhang made even worse by the new shelf registration, this stock is headed to 1.00 or lower until and unless these four variables stop. There is no hint that these things are stopping anytime soon. Europe is delayed likely until Q4 and I don't even want to imagine how bad the stock will perform if we get an FDA denial next month.

No wonder Crede hasn't redeemed the warrants. The best medicine for this stock would be a complete change in management. I bet the pps would surge to 2.50 if Pykett, Tulip, and Larson were forced to step down.

As it is, unfortuntaely, I don't think they are going anywhere and the shareholder lawsuits are really long overdue. Heaven help Larson - he said on the phone more than once to me that another offering would be unnecessary because of the lines of credit that the company has available.

The pay decreases were a good idea, they just didn't go anywhere near far enough. Is Pykett even worth $100K for this bull shit we have been seeing since September? No. I think all hell could break loose at the next shareholder meeting.

Is the company going to be sold for between 1.75 and 2.25 per share? That is how this is starting to look.